Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A-Reference-Cited by-同舟云学术

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A

Published:2002-06 Issue:3 Volume:54 Page:189-201
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Buonaguro L.,Racioppi L.,Tornesello M.L.,Arra C.,Visciano M.L.,Biryahwaho B.,Sempala S.D.K.,Giraldo G.,Buonaguro F.M.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference61 articles.

1. Ugandan HIV-1 V3 loop sequences closely related to the U.S./European consensus;Albert;Virology,1992

2. AIDS vaccine development in primate models;Almond;AIDS,1998

3. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection;Baba;Nat. Med.,2000

4. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition;Boehncke;J. Immunol.,1993

5. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda;Brennan;AIDS,1997

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emergence of nanovaccines as a new paradigm in virological vaccinology: a review;Exploration of Immunology;2023-08-31

2. Virus-like Particle Vaccines and Platforms for Vaccine Development;Viruses;2023-05-02

3. How promising are HIV-1-based virus-like particles for medical applications;Frontiers in Cellular and Infection Microbiology;2022-10-07

4. The current and future role of nanovaccines in HIV-1 vaccine development;Expert Review of Vaccines;2021-06-29

5. The next generation of HCV vaccines: a focus on novel adjuvant development;Expert Review of Vaccines;2021-06-28